Tenax Therapeutics, Inc. is a specialty pharmaceutical company based in Morrisville, North Carolina, dedicated to developing innovative therapies aimed at treating cardiovascular and pulmonary diseases. The company is actively advancing its proprietary drug pipeline, with a strategic focus on addressing significant unmet medical needs within critical care environments across the U.S. and Canada. Through a robust commitment to research and development, Tenax is poised to deliver novel therapeutic solutions that enhance patient outcomes and capitalize on growth opportunities in vital healthcare sectors. Show more
Location: 101 GLEN LENNOX DRIVE, CHAPEL HILL, NC, UNITED STATES, 27517, Chapel Hill, NC, 27517, USA | Website: https://www.tenaxthera.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
78.11M
52 Wk Range
$4.63 - $18.38
Previous Close
$12.51
Open
$12.30
Volume
247,919
Day Range
$12.24 - $13.18
Enterprise Value
408.2M
Cash
99.37M
Avg Qtr Burn
-9.155M
Insider Ownership
0.31%
Institutional Own.
-
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
TNX-103 (Oral Levosimendan) Details Pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF) | Phase 3 Data readout |
